Hemosorption by a Column Adsorber Based on Hyper-Cross-Linked Styrene-Divinylbenzene Copolymer with Immobilized Lipopolysaccharide-Selective Ligand in Combined Intensive Care of Lung Cancer-Related Postoperative Acute Lung Injury (Case Report)

Acute respiratory distress syndrome (ARDS) is a serious challenge in the contemporary reanimatology due to its prevalence, versatility of pathogenesis mechanisms, and continuously high mortality. The development of an uncontrolled cascade of systemic inflammation reactions, ‘cytokine storm’, followed by multiple organ failure (MOF) is an essential pathophysiological trigger of acute lung injury. Besides, critically ill patients are characterized by a relative intestinal ischemia, wherein, according to the ‘intestine-lung axis’ concept that treats intestinal and pulmonary epithelium as a continuous surface, translocation of bacteria and/or endotoxin directly into blood flow might occur. Extracorporeal removal of excessively produced inflammatory response mediators and endotoxin (bacterial lipopolysaccharide, LPS) from systemic circulation by selective hemosorption might represent a life-saving approach in sepsis.

Purpose: to evaluate the efficacy of selective sorption in a combined therapy for acute lung injury related to postoperative injury after lung cancer surgery.

Results. A single 4-hour selective sorption procedure in the combined therapy of a critically ill postoperative patient produced fast (within 24 hrs.) effects: decreased leukocytosis (the leukocyte count fell down from 32X109 to 13X109, L-1) and endotoxin activity (EAA — from 0.67 to 0.32, units), reduced blood plasma anti-inflammatory cytokine (IL-6 — from 1860 to 62, pg/ml) and procalcitonin (PCT — from 46 to 0.32, ng/ml), recovery of gas exchange, discontinuation of hemodynamic support with pressor amines as no longer needed (as early as 2 hours after sorption).

Conclusion. The clinical case of a successful therapy including selective sorption based on hyper-crosslinked styrene-divinylbenzene copolymer with immobilized LPS-selective ligand warrants further clinical studies on the efficiency of a novel selective hemosorption column use to correct post-radical respiratory complications in oncological patients.

1. Kain T., Lindsay P.J., Adhikari N.K.J., Arabi Y.M., Van Kerkhove M.D., Fowler R.A. Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome. Emerg Infect Dis. 2020; 26 (6). DOI: 10.3201/eid2606.200037.

2. Moroz V.V., Golubev A.M. Classification of Acute Respiratory Distress Syndrome. General Reanimatology=Obshchaya Reanimatologiya. 2007; 3 (6): 7–9. [In Russ.]. DOI: 10.15360/1813-9779-2007-6-7-9

3. Moroz V.V., Vlasenko A.V., Golubev A.M., Yakovlev V.N., Alekseyev V.G., Bulatov N.N., Smelaya T.V. The Pathogenesis and Differential Diagnosis of Acute Respiratory Distress Syndrome Induced by Direct and Indirect Etiological Factors. General Reanimatology=Obshchaya Reanimatologiya. 2011; 7 (3): 5. [In Russ.]. DOI: 10.15360/1813-97792011-3-5.

4. Cutts S., Talboys R., Paspula C., Prempeh E.M., Fanous R., Ail D. Adult respiratory distress sendrome. Ann R Coll Surg Engl. 2017; 99 (1): 12–16. DOI: 10.1308/rcsann.2016.0238.

5. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao J., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb; 395 (10223): 497–506. DOI: 10.1016/SO140-6736(20)30183-5.

6. Kopitsyna M.N., Morozov A.S., Bessonov I.V., Pisarev V.M., Lobakova E.S., Bukharin O.V. Ligands for selective removal of lipopolysaccharides from gram negative bacteria. Journal of microbiology, epidemiology and immunobiology=Zhurnal mikrobiologii, epidemiologii i immunobiologii. 2017; (3): 115–126. [In Russ.]. DOI: 10.36233/03729311-2017-3-115-126.

7. Ronco C., Reis T., De Rosa S. Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum. Blood perif. March 9, 2020. DOI: 10.1159/000507039.

8. Albertine K.H., Soulier M.F., Wang Z., Ishizaka A., Hashimoto S., Zimmerman G.A., Matthay M.A., Ware L.B. Fas and Fas Ligand Are Up-Regulated in Pulmonary Edema Fluid and Lung Tissue of Patients with Acute Lung Injury and the Acute Respiratory Distress Syndrome. Am. J. Pathol. 2002; 161 (5): 1783–1796. DOI: 10.1016/s0002-9440(10)64455-0.

9. Doughty L.A., Nguyen K.B., Durbin J.E., Biron C.A. A Role for IFNβ in Virus Infection-Induced Sensitization to Endotoxin. J Immunol. 2001; 166: 2658–2664. DOI: 10.4049/jimmunol.166.4.2658.

10. Kobosz T. COVID-19 może rozpoczynać się od braku apetytu i biegunki. Co to oznacza dla dalszego przebiegu choroby? https://journals.lww.com/ajg/Documents/COVID_ Digestive_Symptoms_AJG_Preproof.pdf.

11. Kumagai T., Takeyama N., Yabuki T., Harada M., Miki Y., Kanou H., Inoue S., Nakagawa T., Noguchi H. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock. 2010; 34 (5): 461–466. DOI: 10.1097/SHK.0b013e3181e14ca0.

12. Kushi H., Miki T., Okamaoto K., Nakahara J, Saito T,Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Critical Care. 2005: 9 (6): 653–661. DOI: 10.1186/cc3815.

13. Lee C.T., Tu Y.K., Yeh Y.C., Shih P.Y., Chao A., Huang H.H., Cheng Y.J., Yeh Y.C. Behalf of the NTUH Center of Microcirculation Medical Research (NCMMR). Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients. J. Crit. Care. 2018; 43: 202–206. DOI: 10.1016/j.jcrc.2017.04.035.

14. Nishibori M., Takahashi H.K., Katayama H., Nishibori M., Mori S., Saito S., Iwagaki H., Tanaka N., Morita K., Ohtsuka A. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Medica Okayama.2009; 63 (1): 65–69. DOI: 10.18926/amo/31855.

15. Ono S., Kimura A., Hiraki S., Takahata R, Tsujimoto H, Kinoshita M, Miyazaki H.,Yamamoto J., Hase K., Saitoh D. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers. Surgery. 2013; 153 (2): 262–271. DOI: 10.1016/j.surg.2012.06.023.

16. Cutts S., Talboys R., Paspula C., Prempeh E.M., Fanous R., Ail D. Adult respiratory distress sendrome. Ann R Coll Surg Engl. 2017; 99 (1): 12–16. DOI: 10.1308/rcsann.2016.0238.

17. Ushakova N.D., Kit O.I., Maslov A.A., Men'shenina A.P. Extracorporeal Detoxification in Abdominal Sepsis in Cancer Patients. General Reanimatology=Obshchaya Reanimatologiya. 2018; 14 (2): 25–34. [In Russ.]. DOI: 10.15360/1813-9779-2018-2-25-34.

18. Morozov A.S., Kopitsyna M.N., Bessonov I.V., Karelina N.V., Nuzhdina A.V., Sarkisov I.Yu., Pavlova L.A., Tsyurupa M.P., Blinnikova Z.K., Davankov V.A. Селективный сорбент для удаления из крови бактериальных эндотоксинов. Zhurnal fiz. khimii. 2016; 90 (12): 1876–1882 [In Russ.]. DOI: 10.7868/S0044453716120165.

19. Khoroshilov S.E., Nikulin A.V., Bessonov I.V., Morozov A.S.,Yarema I.V. Efficacy and Safety of a Novel Adsorber for LPS-Selective Hemosorption (Experimental Study). General Reanimatology=Obshchaya Reanimatologiya. 2018; 14 (6): 51–60. [In Russ.]. DOI: 10.15360/18139779-2018-6-51-60.